Inositol hexakisphosphate kinase-2 acts as an effector of the vertebrate Hedgehog pathway.
Inositol phosphate (IP) kinases constitute an emerging class of cellular kinases linked to multiple cellular activities. Here, we report a previously uncharacterized cellular function in Hedgehog (Hh) signaling for the IP kinase designated inositol hexakisphosphate kinase-2 (IP6K2) that produces diphosphoryl inositol phosphates (PP-IPs). In zebrafish embryos, IP6K2 activity was required for normal development of craniofacial structures, somites, and neural crest cells. ip6k2 depletion in both zebrafish and mammalian cells also inhibited Hh target gene expression. Inhibiting IP(6) kinase activity using N(2)-(m-(trifluoromethy)lbenzyl) N(6)-(p-nitrobenzyl)purine (TNP) resulted in altered Hh signal transduction. In zebrafish, restoring IP6K2 levels with exogenous ip6k2 mRNA reversed the effects of IP6K2 depletion. Furthermore, overexpression of ip6k2 in mammalian cells enhanced the Hh pathway response, suggesting IP6K2 is a positive regulator of Hh signaling. Perturbations from IP6K2 depletion or TNP were reversed by overexpressing smoM2, gli1, or ip6k2. Moreover, the inhibitory effect of cyclopamine was reversed by overexpressing ip6k2. This identified roles for the inositol kinase pathway in early vertebrate development and tissue morphogenesis, and in Hh signaling. We propose that IP6K2 activity is required at the level or downstream of Smoothened but upstream of the transcription activator Gli1.
Sarmah
Bhaskarjyoti
B
Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232-8240, USA.
Wente
Susan R
SR
D000818:Animals; D002465:Cell Movement; D019465:Craniofacial Abnormalities / Q000196:embryology / Q000201:enzymology / Q000473:pathology; D004622:Embryo, Mammalian / Q000201:enzymology / Q000473:pathology; D047108:Embryonic Development / Q000235:genetics; D018507:Gene Expression Regulation, Developmental; D055785:Gene Knockdown Techniques; D053823:Hedgehog Proteins / Q000378:metabolism*; D007295:Inositol Phosphates / Q000378:metabolism; D051379:Mice; D041681:NIH 3T3 Cells; D009432:Neural Crest / Q000201:enzymology / Q000473:pathology; D017856:Phosphotransferases (Phosphate Group Acceptor) / Q000378:metabolism*; D015398:Signal Transduction; D019170:Somites / Q000002:abnormalities / Q000201:enzymology / Q000473:pathology; D015027:Zebrafish / Q000196:embryology / Q000235:genetics / Q000378:metabolism*; D029961:Zebrafish Proteins / Q000378:metabolism*
D053823:Hedgehog Proteins; D007295:Inositol Phosphates; D029961:Zebrafish Proteins; D017856:Phosphotransferases (Phosphate Group Acceptor); C099438:inositol hexakisphosphate kinase; C554280:ip6k2a protein, zebrafish